Inclisiran

Inclisiran for cholesterol: Docs call it expensive, bat for cheaper options

Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed on better use of the much cheaper versions available. Jan 14, 2024
Ayurveda

Ayurveda's role in enhancing kidney health and overall renal function

In recent years, India has become a global hub for medical tourism, attracting people from all corners of the world seeking high-quality and holistic healthcare solutions. One significant contributor to this success is Ayurveda, the ancient Indian system of medicine. Jan 10, 2024